Dr. Klingman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
413 Gilmoure Dr
Silver Spring, MD 20901Phone+1 240-281-1511
Summary
- Dr. Karin Klingman is a healthcare provider based in Silver Spring, MD, with a specialty in Infectious Disease and a subspecialty in HIV/AIDS Medicine. She completed her Internal Medicine/Pediatrics Residency at St Louis University School of Medicine and later a Fellowship in Infectious Disease at the University at Buffalo. Reading from her professional academic history, Dr. Klingman is from the Class of 1983 at Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. She worked for 20 years at the Division of AIDS at NIAID as a Medical Officer, working mainly with the clinical trials networks on several pivotal trials that advanced the treatment of HIV, including SMART, START, PROMISE, and REPRIEVE. She retired from federal service and now works on clinical trials as a consultant and contractor, with expertise in safety, innovative design and implementation.
Education & Training
- University at BuffaloFellowship, Infectious Disease, 1987 - 1990
- St Louis University School of MedicineResidency, Internal Medicine/Pediatrics, 1983 - 1987
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1983
Certifications & Licensure
- MD State Medical License 2000 - 2026
- NY State Medical License 1987 - 2020
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- NIH Directors Award NIH, 2022
Publications & Presentations
PubMed
- 97 citationsRationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).Steven K. Grinspoon, Kathleen V. Fitch, Edgar T. Overton, Carl J. Fichtenbaum, Markella V. Zanni
American Heart Journal. 2019-03-04 - 1903 citationsCirculating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a c...Daniel D Murray, Kazuo Suzuki, Matthew Law, Jonel Trebicka, Jacquie Neuhaus
Plos One. 2015-10-14 - 1655 citationsCD4+ count-guided interruption of antiretroviral treatment.Wafaa El-Sadr, Jens D Lundgren, James D. Neaton, Fred M. Gordin, Dominic Abrams
The New England Journal of Medicine. 2006-11-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: